Although AD is primarily driven by Th2-mediated responses, severe or treatment-resistant cases have shown involvement of interleukin-17 (IL-17), a cytokine typically associated with PSO pathogenesis (10). This evidence concerns the gene IL17A and Alzheimer disease.